CLINICAL_TRIALS trial_result · 2016-10-10

Clinical Trial Update: Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Induced Angioedema [Phase 3]

Phase 3 blinded safety and efficacy trial of icatibant for ACE inhibitor-induced angioedema has completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Shire | Conditions: Angiotensin Converting Enzyme Inhibitor Induced Angioedema | Phase 3 | Status: COMPLETED | Results posted: 2016-10-10